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INTRODUCTION
H pylori is a spiral gram negative microaerophilic bacterium 
that infects the human gastric mucosa and is associated with 
gastritis, gastroduodenal ulcer disease, gastric carcinoma 
and mucosal associated lymphoid tissue lymphoma[1,2]. 
The prevalence of  H pylori is high in developing countries. 
A recent study revealed an early colonization/infection 
of  infants with H pylori and a prevalence of  67% at 9 mo 
of  age in a peri-urban community in Karachi, Pakistan[3]. 
H pylori serology was positive in 58% of  our general 
population in a previous study but is likely to actually be 
higher[4]. Currently, several diagnostic tests of  varying 
sensitivity and specificity are available for determining 
the presence of  H pylori, which include rapid urease test 
(RUT), histology, culture, urea breath test (UBT), and 
serology. Isolation of  H pylori from gastric biopsy specimens 
constitutes the most specific way to establish the diagnosis 
of  infection and to study the genotype of  the infecting 
strains, however, it is a time consuming process. RUT and 
histology are still commonly used for the diagnosis of  
H pylori infection in our country as other modalities of  
H pylori testing, such as UBT and facilities for H pylori stool 
antigen tests, are not widely available. 
In Pakistan, se l f -prescr ipt ion is common and 
medications are available over the counter without 
prescriptions[5]. It is known that acid reducing drugs; 
e.g, proton pump inhibitor (PPI), histamine-2 receptor 
blocker (H2RB), antibiotics and bismuth compounds 
reduce the sensitivity and specificity of  the diagnostic tests 
for H pylori[6,7]. In our previous studies, we demonstrated 
that histology is comparatively less affected by PPI than 
RUT[8,9]. Polymerase chain reaction (PCR) is a highly 
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Abstract
AIM: To determine the efficacy of gastric juice polymerase 
chain reaction (PCR) for the detection of H pylori infection 
in comparison with histology and gastric antral biopsy PCR 
in patients on a proton pump inhibitor (PPI).
METHODS: Eighty-five consecutive patients with 
dyspeptic symptoms were enrolled. Gastric biopsies 
for histology, PCR and gastric juice were collected at 
endoscopy for PCR of the H pylori  urease C gene (ure 
C). Sensitivity, specificity, positive predictive value (PPV), 
negative predictive value (NPV), accuracy, positive and 
negative likelihood ratio for PCR of gastric juice for the 
H pylori  ure C gene was compared to histology and 
gastric antral biopsy H pylori  ure C PCR in patients with 
and without PPI. 
 
RESULTS: Gastric juice PCR was positive in 66 (78%) 
patients. Histology showed H pylori  associated gastritis 
in 57 (67%). Gastric biopsy PCR was positive in 72 (85%). 
In patients not taking PPI, the sensitivity, specificity, PPV, 
NPV, accuracy and positive and negative likelihood ratio 
for gastric juice PCR were 89%, 72%, 91%, 67%, 90%, 
85%, 3.1 and 0.1 respectively. In patients on PPI these 
values were 86%, 100%%, 100%, 29%, 86%, 9.5 and 
1.4, respectively. 
 
CONCLUSION: Gastric juice PCR for the diagnosis of 
H pylori  infection has increased sensitivity compared 
to histology with PPI. The use of gastric juice PCR is 
recommended to confirm H pylori status in patients 
taking PPIs.
© 2008 WJG. All rights reserved.
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sensitive technique that can detect very small amounts of  
DNA. The DNA molecule is chemically stable and can 
survive in the environment for long periods[10]. PCR may 
be useful, therefore, in detecting the presence of  H pylori, 
even when the organism is in a nonculturable state. In 
previous studies, gastric juice PCR has been evaluated as 
a highly specific and rapid method for the detection of  
H pylori[11,12]. An efficient and accurate diagnosis of  H pylori 
infection is important when seeking to cure patients with 
persistent gastric symptoms in which H pylori infection 
is suspected. The aim of  this study was to determine the 
efficiency of  gastric juice PCR for the detection of  H pylori 
infection in patients on PPI and compare it with histology 
and gastric biopsy PCR.
MATERIALS AND METHODS
Patients
Eighty-five consecutive patients with dyspeptic symptoms 
attending the gastroenterology outpatient clinic from 
February-November 2006 were enrolled. There were 58 
(68%) males and 27 (32%) females. The age range was 
17-70 years with a mean age of  36.8 ± 11. Patients were 
divided into two groups: (1) those who received PPI (mainly 
omeprazole 20 mg once a day) for at least 4 wk before 
undergoing esophagogastroduodenoscopy (EGD); (2) 
patients with no previous treatment with antibiotics, PPI, 
H2RB and bismuth compounds. Patients in each respective 
group also did not use other drugs. Compliance with 
treatment was ascertained during an outpatient visit before 
the endoscopy. The study was approved by the Ethics 
Review Committee of  Aga Khan University Hospital. 
Informed consent was obtained from all patients for EGD 
with biopsies from the antrum and corpus of  the stomach 
and aspiration of  gastric juice. EGDs were performed 
after an 8 h fast. A sample of  gastric juice (5 mL) was 
aspirated at endoscopy by means of  a sterile cannula 
used for endoscopic retrograde cholangiopancretography 
(ERCP), passed through the suction channel and collected 
in a disposable sterile syringe. After each examination 
the endoscopes were washed with 2% glutaraldehyde 
and disinfected with 70% ethanol followed by rinsing 
with sterile water after each examination. Biopsy forceps 
were sterilized by autoclaving to ensure lack of  cross 
contamination using the endoscopic equipment. All 
patients received conscious sedation with intravenous 
midazolam and topical pharyngeal anesthetic spray. 
Sterilized biopsy forceps were used to obtain gastric 
biopsy specimens from the antrum and mid of  the 
corpus. Two biopsy specimens were removed from each 
site for histology and dispatched in a formalin containing 
container. Biopsy for PCR was dispatched in normal 
saline. Sensitivity, specificity, PPV, NPV, accuracy, positive 
and negative likelihood ratio for gastric juice H pylori ure 
C gene PCR were compared against histology and gastric 
biopsy PCR in patients with and without PPI to establish 
the efficiency of  this diagnostic approach. 
 
Histology
Gastric biopsy specimens from each site for histopathology 
were stained with hematoxylin and eosin and Giemsa 
stain for the detection of  H pylori; the degree of  gastritis 
as determined by hematoxylin and eosin (HE) stain was 
scored in accordance with the Sydney system[13].
Extraction of genomic DNA from gastric juice 
Extraction of  genomic DNA from gastric juice was carried 
out as previously described[11]. A 5 mL of  gastric juice 
aspirate was buffered to a neutral pH with 5 mL of  Tris 
(0.67 mol/L, pH 7.4). Each sample was then concentrated 
by centrifugation at 10 000 × g for 20 min. The supernatants 
were removed and the pellets were resuspended in 100 μL 
of  sterile distilled water. One hundred μL of  lysis buffer 
[100 mmol/L NaCl, 10 mmol/L Tris-HCl (pH 8.0), 
25 mmol/L EDTA, 0.5% sodium dodecyl sulfate], and 
5 μL of  proteinase K (10 g/L) were added. Incubation was 
carried out at 50℃ for 20 h; this was followed by phenol-
chloroform extraction and ethanol precipitation. The 
resulting pellet was allowed to dissolve in 35 μL of  TE 
buffer 10 mmol/L Tris-HCl (pH 7.4) and 0.1 mmol/L EDTA 
(pH 8.0) for 20 h at 37℃. Samples were stored at -20℃ 
before PCR amplification was performed. DNA content 
and purity was determined by measuring the absorbance at 
260 nm and 280 nm using a spectrophotometer (Beckman 
DU-600, USA). 
Extraction of DNA from gastric biopsy
Briefly, gastric tissue was homogenized to uniformity in 
500 mL of  sterile water and centrifuged at 12 000 × g 
for 3 min. Five hundred μL of  lysis buffer [100 mmol/L 
NaCl, 10 mmol/L Tris-HCl (pH 8.0), 25 mmol/L EDTA, 
0.5% sodium dodecyl sulfate], and 10 μL of  proteinase K 
(10 g/L) were added. Incubation was carried out at 56℃ for 
20 h; this was followed by phenol-chloroform extraction 
and ethanol precipitation. The resulting pellet was allowed 
to dissolve in 40 μL of  TE buffer [10 mmol/L Tris-HCl 
(pH 7.4) and 0.1 mmol/L EDTA (pH 8.0)] for 20 h at 37℃. 
Samples were stored at -20℃ before PCR amplification was 
performed. DNA content and purity was determined by 
measuring the absorbance at 260 nm and 280 nm using a 
spectrophotometer (Beckman DU-600, USA). 
PCR for ure C
PCR was performed using extracted DNA as the template 
and urease gene C for primers. Forward primer (5'-TG
GGACTGATGGCGTGAGGG-3') and reverse primer 
(5'-AAGGGCGTTTTTAGATTTTT-3') were prepared 
from the urease gene sequence according to the report 
of  Labigne et al[14]. PCR amplification was carried out in 
a total volume of  50 μL containing 2 μL of  2 mmol/L 
dNTPs, 1 μL containing 50 ρmol of  primer 1, 1 μL 
containing 50 ρmol of  primer 2 (synthesized by ABI 
Automatic synthesizer), 1 unit of  Taq DNA polymerase 
(Promega), 5 μL of  10 × PCR reaction buffer, 3 mmol/L 
of  MgCl2, 2 μL of  DNA template containing 0.5 ng of  
extracted DNA and total volume rounded to 50 μL by 
double distilled water. The reaction was carried out in a 
Perkin Elmer 9700 thermal cycler. The amplification cycle 
consisted of  an initial denaturation of  target DNA at 95℃ 
for 5 min and then denaturation at 94℃ for 1 min, primer 
1540        ISSN 1007-9327       CN 14-1219/R      World J Gastroenterol      March 14, 2008    Volume 14     Number 10
www.wjgnet.com
annealing at 56℃ for 1 min and extension at 72℃ for 
1 min. The final cycle included an extension step for 5 min 
at 72℃ to ensure full extension of  the product. Samples 
were amplified through 35 consecutive cycles. Negative 
reagent control reactions were performed with each batch 
of  amplifications, consisting of  tubes containing distilled 
water in place of  the DNA samples. Five μL of  PCR 
product was electrophoresed on a 1.5% agarose gel to 
ensure homogeneity and yield. PCR amplification resulted 
in a homogeneous DNA fragment of  the expected size of  
820 bp for ure C gene.
Statistical analysis
The statistical package for social science SPSS (Release 
11.5, standard version, copyright © SPSS; 1989-99) was 
used for data analysis. The descriptive analysis was done for 
demographic and clinical features. Results were presented 
as mean ± SD for quantitative variables and number 
(percentage) for qualitative variables. Odd ratio (OR) and 
95% confidence interval (95% CI) were estimated to check 
the strength of  association. Sensitivity, specificity, PPV, 
NPV, accuracy and negative and positive likelihood ratio 
were determined for PCR and histology.
RESULTS
Thirty seven (43.5%) patients were on PPI while 48 (56.5%) 
were not taking any medications. Abdominal pain was 
present in 60 (71%) and dyspepsia 25 (29%). Symptoms 
were equally common in two groups. The endoscopic 
diagnosis was pangastric erythema in 56 (66%), antral 
erythema in 25 (29.4%), gastric ulcer 1 (1.2%), gastric 
carcinoma 2 (4.2%), and duodenal ulcer 1 (1.2%). The age 
range of  these patients was 25-70 years with mean age 
43.5 ± 13.2.
Comparison of histology, gastric biopsy and juice PCR 
with and without PPI
Histology showed H pylori associated gastritis in 57 (67%) 
and H pylori negative gastritis in 28 (33%). On PPI, 23 (62%) 
had H pylori positive gastritis P = 0.24 (Table 1). Gastric 
juice ure C PCR was positive in 66 (78%) and negative 
in 19 (22%). On PPI, gastric juice PCR was positive in 
30 (81%) P = 0.50 (Table 1). Gastric biopsy ure C PCR 
was positive in 72 (85%) and negative in 13 (15%). On 
PPI, gastric biopsy PCR was positive in 35 (95%) with P = 
0.02 (Table 1).
Comparison of histology and gastric juice PCR with 
gastric biopsy PCR
Seventy two (85%) were positive by ure C PCR of  gastric 
biopsy compared to 57 (67%) by histology and 66 (78%) 
by gastric juice ure C PCR with P < 0.001 and P < 0.001, 
respectively (Table 2). For patients taking PPI, 23 (62%) 
were positive by histology while 30 (81%) were positive by 
gastric juice PCR with P = 0.17 and P = 0.003, respectively 
(Table 2). For patients not taking PPI, histology was positive 
in 34 (71%) while 36 (75%) were positive by gastric juice 
PCR with P < 0.001 and P < 0.001, respectively (Table 2). 
For patients taking PPI, the sensitivity, specificity, PPV, 
NPV, accuracy and positive and negative likelihood ratio for 
gastric juice PCR and histology were 86%, 100%, 100%, 
29%, 86%, 9.5 and 1.4 and 73%, 100%, 100%, 14%, 0.6 and 
2.7, respectively (Table 3).
DISCUSSION
Gastric juice represents a pooled source of  events in the 
entire gastric microenvironment, and it may be valuable 
for studying H pylori whose mucosal distribution is patchy 
and variable. This is even more relevant in the setting of  
developing countries, where H pylori possibly exists as a 
dynamic mix of  quasi-species. A single biopsy sample may 
not be able to detect the presence of  H pylori, whereas 
gastric juice, being a more global sample, may overcome 
this limitation because the gastric juice reflects the actual 
microenvironment and the global level of  infection in 
the stomach. H pylori has a very potent urease activity, 
and because of  this highly specific activity of  the urease 
enzyme H pylori are able to hydrolyze the urea present in 
Table 1  Comparison of histology, gastric biopsy and juice PCR 
for the diagnosis of H pylori  infection with and without PPI  n (%)
Medication P  value
On PPI  Without PPI    
n  = 37  n  = 48
Histology
   H pylori positive gastritis 23 (62) 34 (71) 0.24
   H pylori negative gastritis 14 (38) 14 (29)
Gastric juice PCR
   Positive 30 (81) 36 (75) 0.50
   Negative   7 (19) 12 (25)
Gastric biopsy PCR
   Positive 35 (95) 37 (77) 0.02
   Negative 2 (5) 11 (23)
Table 2  Comparison of gastric juice PCR and histology using 
gastric biopsy PCR as the gold standard  n  (%)
PCR of gastric biopsy P  value
Over all (n = 85)
Histology Positive Negative
   Positive 56 (78) 1 (8) < 0.001
   Negative 16 (22) 12 (92)
Gastric juice PCR
   Positive 63 (87)   3 (23) < 0.001
   Negative   9 (13) 10 (77)
On PPI (n = 37)
   Histology
   Positive 23 (66) 0   0.17
   Negative 12 (34)     2 (100)
Gastric juice PCR
   Positive 30 (86) 0     0.003
   Negative   5 (14)     2 (100)
No PPI (n = 48)
Histology
   Positive 33 (89) 1 (9) < 0.001
   Negative   4 (11) 10 (91)
Gastric juice PCR
   Positive 33 (89)   3 (27) < 0.001
   Negative   4 (11)   8 (73)
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the stomach. This serves to protect the organism from the 
harmful effects of  gastric acid and the ammonia generated 
protects the organism by buffering gastric acid[15,16]. The 
proton pump inhibitor reduces gastric acid secretion and 
inhibits urease activity[17,18]. When the secretion of  acid 
is suppressed, H pylori in the presence of  urea increases 
the pH of  its local environment to alkaline values and are 
unlikely to survive in a culturable form[19].    
This study has demonstrated that for patients taking 
PPI gastric juice H pylori PCR with a specific primer 
for ure C was more sensitive than histology to detect 
H pylori infection 86% vs 73% (Table 3). Gastric juice 
PCR was able to detect positively 7 (19%) patients who 
were negative on histology. This could be due to a patchy 
distribution of  the H pylori, obtaining biopsies from an 
uninfected sites resulting in false negatives on histology 
and PPI activity against H pylori[20]. The histology-negative, 
PCR-positive subjects were older, with a mean age of  
43.5 ± 13.2 years. This is in keeping with a previous study[21]. 
H pylori infection associated atrophy and intestinal metaplasia 
progresses with age[22,23]. Thus, older patients may be more 
liable to have false-negative results from the commonly 
biopsied sites in our practice. Although, the overall 
sensitivity of  the gastric juice PCR as seen in the present 
study is low. This might be attributed either to the lack of  
H pylori in the gastric juice or the presence of  some inhibitor 
of  PCR decreasing sensitivity of  the technique. In this 
study, we did not choose to compare RUT with gastric juice 
PCR as it is already known that PPI reduces the sensitivity 
of  RUT[7-9]. In patients on PPI, the biopsy specimen 
may contain low bacterial density of  viable cells giving a 
negative urease test. This will also lead to the lack of H pylori 
identification on histology. Similarly, culture of  H pylori from 
gastric mucosal biopsies is likely to be negative with PPI as 
they are not only known to effect the distribution of  H pylori 
within the stomach but are also detrimental to H pylori in 
both the antrum and the corpus[7,24].
Proton pump inhibitors have been reported to modify 
the level of  H pylori gastritis[20,25,26]. The sensitivity, NPV, 
accuracy and positive likelihood ratio of  gastric juice PCR 
was greater and the negative likelihood ratio was less for 
H pylori in patients on PPI, while specificity and PPV was 
similar to histology (Table 3). A previous study by Dickey 
et al showed histological examination sensitivity, specificity, 
PPV, NPV and diagnostic accuracy were reduced on 
acid reducing drugs[7]. In their study, five (83%) of  the 
histology-negative, seropositive patients taking PPI had 
histological changes consistent with H pylori gastritis 
even though no H pylori were detected[7]. In our study, 
the detection rate of  H pylori was greater by gastric juice 
PCR on PPI (Tables 1-3). Of  the various tests that are 
available for H pylori detection, histological examination of  
gastric biopsy is considered the most accurate method of  
diagnosis[27]. If  more than one gastric biopsy tissue is used 
it might improve the test sensitivity without compromising 
its specificity. Obtaining a serological test in these cases 
in our population, will not help in deciding whether to 
treat or not, as a positive result with serology does not tell 
whether the patient has a current infection or had a past 
infection that is now cured. The drawbacks of  treating 
these patients who are not actively infected include among 
many others contribution to antibiotic resistance. 
This is the first study to investigate influence of  PPI 
on the results of  PCR of  gastric juice and histological 
examinations while using gastric biopsy PCR as the gold 
standard. In the presence of  PPI, gastric juice PCR was 
more sensitive than histology. Seven (19%) subjects who 
were negative for H pylori by histology and positive by 
the gastric juice PCR assay should be regarded as having 
ongoing infections. These patients would have benefited 
from antimicrobial therapy. However, the results of  this 
study needs to be confirmed in a larger group of  patients. 
In conclusion, the use of  the gastric juice PCR can be 
recommended to exclude H pylori infection in patients 
taking PPI. However, it can also be used as an additive test 
to confirm the H pylori status in patients having histological 
changes consistent with H pylori gastritis though negative 
for H pylori. 
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COMMENTS
Background
An efficient and accurate diagnosis of H pylori infection is important when seeking 
to cure patients with persistent gastric symptoms in which H pylori infection is 
suspected. In patients on acid reducing drugs such as proton pump inhibitors 
(PPI), H-2 receptor blockers (H-2RB) etc, the accuracy of the rapid urease test, 
urea breath test and histology are known to be less accurate for the diagnosis of H 
pylori infection. 
Table 3  Comparison of gastric juice PCR and histology with and without PPI using gastric biopsy PCR as  the gold standard
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Likelihood ratio LR+ Likelihood ratio LR- Accuracy (%)
Over all (n = 85)
Histology 77   92   98 43 9.6   0.25 80
Gastric juice PCR 87   77   95 53 3.7   0.16 85
On PPI (n = 37)
Histology 73 100 100 14 0.6 2.7 74
Gastric juice PCR 86 100 100 29 9.5 1.4 86
No PPI (n = 48)
Histology 89   90   97 71   0.89   0.12 85
Gastric juice PCR 89   72   91 67   3.17   0.15 85




The development of new types of test or targets to test for the H pylori infection 
in patients with prior use of PPI etc is important considering the morbidity and 
mortality associated with this infection.
Innovations and breakthroughs
This study determined the efficiency of gastric juice polymerase chain reaction 
(PCR) for the detection of H pylori infection in patients on PPI and compared it 
with histology and gastric biopsy PCR.
Applications 
It showed gastric juice PCR for the diagnosis of H pylori infection had an increased 
sensitivity compared to histology in patients on PPI. The use of the gastric juice 
PCR can be recommended to confirm the H pylori status in patients taking PPIs.
Terminology
PPI: proton pump inhibitors are a group of drugs whose main action is pronounced 
and long-lasting reduction of gastric acid production. They are the most potent 
inhibitors of acid secretion available today.
Peer review
The paper means a real advance in the methodology of diagnosis in this field. The 
conclusions are valuable. The design is original. The methodology is correct and 
the results are well presented. Statistical analysis is adequate. 
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